secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0001558370-23-006578
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kala Pharmaceuticals stockholders approve option exchange and auditor ratification at special meeting
--------------------------------------------------------------------------------

- Option exchange proposal approved: 385,429 for, 57,585 against, 525,624 broker non-votes.
- Ratification of Deloitte & Touche as auditor for FY2023 approved: 937,505 for, 23,974 against.
- Adjournment proposal approved: 873,292 for, 94,743 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000155837023006578/0001558370-23-006578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000155837023006578/kala-20230424x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-006578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer